Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 19
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
BrightSpring Health Services Inc
BTSG
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$61.35
0.48
0.79%
Ult. Agg.: Oct 19, 9:24 AM
$61.35
0.48
0.79%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Utili:
I risultati di Q3 2026 tra 11 giorni da adesso in ven ott 30th, prima dell'apertura del mercato
BrightSpring Health Financials
BrightSpring Health (BTSG) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share
Benzinga Newsdesk
PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B Est
BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate.
Benzinga Newsdesk
BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results
BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. Analysts have raised price targets for stock.
Avi Kapoor
BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast
BrightSpring shares rise after Q1 earnings beat, revenue growth and raised FY26 guidance; analysts cite momentum but note valuation premium.
Vandana Singh
Earnings Scheduled For May 1, 2026
Benzinga Insights
PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.450B-$15.000B to $14.725B-$15.225B vs $14.847B Est
Full Year 2026 Financial GuidanceFor the full year 2026, BrightSpring is increasing Revenue and Adjusted EBITDA guidance, which excludes the Community Living business and the effects of any future closed acquisitions.
Benzinga Newsdesk
